The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Global survey on barriers to clinical cancer research.
Tanja Cufer
No relevant relationships to disclose
Eduardo L. Cazap
Consultant or Advisory Role - Bayer; Schering Pharma
Honoraria - Bayer; Bristol-Myers Squibb; Fresenius Biotech
Research Funding - Breast Cancer Research Foundation; Daiichi Sankyo; Poniard Pharmaceuticals
Lucia Beatriz Delgado
Research Funding - Roche
Other Remuneration - Pfizer
Raghunadharao Digumarti
No relevant relationships to disclose
Natasha B. Leighl
Research Funding - AstraZeneca; Roche
Mohamed M. Meshref
Employment or Leadership Position - Boehringer Ingelheim
Hironobu Minami
No relevant relationships to disclose
Eliezer Robinson
No relevant relationships to disclose
Nise Hitomi Yamaguchi
No relevant relationships to disclose
Aleksander Sadikov
No relevant relationships to disclose
Bostjan Seruga
No relevant relationships to disclose
Doug Pyle
No relevant relationships to disclose